Advanced search
Publication Cover
Clinical Ophthalmology Volume 16, 2022 - Issue
Submit an article Journal homepage
216
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Cost–Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany

Carlo Lazzaro1 Health Economist and Research Director, Studio di Economia Sanitaria, Milan, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4795-1834View further author information
ORCID Icon,
Cécile van Steen2 Santen GmbH, München, GermanyORCID Iconhttps://orcid.org/0000-0002-8872-2678View further author information
ORCID Icon,
Stephan Billeit3 Private Practicing Ophthalmologist, Lübeck, GermanyView further author information
,
Heinrich Frauenknecht4 Private Practicing Ophthalmologist, Treuchtlingen, GermanyView further author information
,
Christopher Kallen5 Private Practicing Ophthalmologist, Krefeld, GermanyORCID Iconhttps://orcid.org/0000-0002-9365-4841View further author information
ORCID Icon,
Stefan Pfennigsdorf6 Private Practicing Ophthalmologist, Polch, GermanyView further author information
,
Ulrich Thelen7 Private Practicing Ophthalmologist, Münster, Germany;8 University Hospital Muenster, Department of Ophthalmology, Münster, GermanyView further author information
&
Luigi Angelillo2 Santen GmbH, München, GermanyORCID Iconhttps://orcid.org/0000-0002-5372-9730View further author information
ORCID Icon show all
Pages 323-337 | Published online: 09 Feb 2022

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carlo Lazzaro, Cécile van Steen, Giorgio Ghirelli, Matteo Sacchi, Dario Sisto, Maurizio Uva, Luigi Varano & Luigi Angelillo. (2023) A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis. Expert Review of Pharmacoeconomics & Outcomes Research 23:2, pages 251-265.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.